A randomized, double-blind, placebo-controlled, single center study designed to assess the effects of pregabalin on change in patients with diabetic neuropathy
Phase of Trial: Phase IV
Latest Information Update: 23 Sep 2014
At a glance
- Drugs Pregabalin (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Pharmacodynamics
- 09 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jan 2008 New trial record.